Search results
“We’ve got to step up and help these companies get to that next level” – new investor Ahimsa...
Just Food via Yahoo Finance· 6 days agoMatt Tullman, one of Ahimsa Companies’ investors and its CEO, talks the recent slowdown in the...
Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma
Clinical Trials Arena via Yahoo Finance· 2 hours agoThe incidence and severity...Naporafenib, which has received fast track designation from the US Food...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 1 day agoRegeneron said that the therapy is under review by the US Food and Drug Administration with a target...
Gateway - Quartz
Quartz· 5 hours agoTupperware, a legacy brand in turmoil, is gearing up for a turnaround. It has finalized an agreement with its lenders to restructure its existing debt obligations, the food
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 5 days agoMore companies, like Pfizer Amgen and Roche, are now in the mix as well. Lilly scientists have about...
This nutrition scientist is on a mission to make ultra-processed foods healthier. Can he succeed?
INSIDER via Yahoo News· 3 days ago(Already, big food companies including Nestle are refomulating some packaged foods like frozen...
At Cannes, the ad industry contemplates its AI future with a mix of hope and fear
Fortune· 2 hours agoAt Cannes, many of the world’s biggest agencies—WPP, Publicis, Havas, and Dentsu—announced plans to use AI. AI may let brands bypass them entirely and use AI to design their own campaigns. In ...
Video Shows Uncontacted Tribe Beg For Food From Miners Who Destroy Their Land
IFLScience· 5 days agoA shocking new video shows members of an uncontacted tribe in Indonesia approach the miners who are...
Corus CEO Doug Murphy Exits After Losing Warner Bros. Discovery Channels
The Hollywood Reporter via Yahoo Finance· 1 day agoCorus Entertainment has replaced president and CEO Doug Murphy with co-CEOs a week after the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
